Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency.

Atherosclerosis develops rapidly in patients with diabetes or renal insufficiency. Plasma lipoprotein profiles are frequently abnormal in these conditions and reflect an elevation in the level of the apoprotein B (ApoB)-containing components very low density lipoprotein (VLDL) and low density lipopr...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Proc Natl Acad Sci U S A
Principais autores:	Bucala, R, Makita, Z, Vega, G, Grundy, S, Koschinsky, T, Cerami, A, Vlassara, H
Formato:	Artigo
Idioma:	Inglês
Publicado em:	National Academy of Sciences 1994
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC44828/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7937786/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.91.20.9441
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!